16-2088881-G-GCGCACACA
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001009944.3(PKD1):c.*845_*846insTGTGTGCG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.040 ( 205 hom., cov: 0)
Exomes 𝑓: 0.014 ( 21 hom. )
Consequence
PKD1
NM_001009944.3 3_prime_UTR
NM_001009944.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.365
Publications
1 publications found
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 16-2088881-G-GCGCACACA is Benign according to our data. Variant chr16-2088881-G-GCGCACACA is described in ClinVar as [Benign]. Clinvar id is 1279025.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0885 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.*845_*846insTGTGTGCG | 3_prime_UTR_variant | Exon 46 of 46 | 1 | NM_001009944.3 | ENSP00000262304.4 | |||
TSC2 | ENST00000219476.9 | c.*272_*273insGCACACAC | 3_prime_UTR_variant | Exon 42 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 |
Frequencies
GnomAD3 genomes AF: 0.0405 AC: 5930AN: 146468Hom.: 204 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5930
AN:
146468
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0139 AC: 3822AN: 274468Hom.: 21 Cov.: 0 AF XY: 0.0135 AC XY: 1952AN XY: 145068 show subpopulations
GnomAD4 exome
AF:
AC:
3822
AN:
274468
Hom.:
Cov.:
0
AF XY:
AC XY:
1952
AN XY:
145068
show subpopulations
African (AFR)
AF:
AC:
491
AN:
7156
American (AMR)
AF:
AC:
164
AN:
10068
Ashkenazi Jewish (ASJ)
AF:
AC:
140
AN:
8414
East Asian (EAS)
AF:
AC:
0
AN:
18718
South Asian (SAS)
AF:
AC:
240
AN:
36214
European-Finnish (FIN)
AF:
AC:
301
AN:
14032
Middle Eastern (MID)
AF:
AC:
18
AN:
1090
European-Non Finnish (NFE)
AF:
AC:
2231
AN:
163308
Other (OTH)
AF:
AC:
237
AN:
15468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
136
271
407
542
678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0405 AC: 5936AN: 146572Hom.: 205 Cov.: 0 AF XY: 0.0406 AC XY: 2908AN XY: 71682 show subpopulations
GnomAD4 genome
AF:
AC:
5936
AN:
146572
Hom.:
Cov.:
0
AF XY:
AC XY:
2908
AN XY:
71682
show subpopulations
African (AFR)
AF:
AC:
3406
AN:
37404
American (AMR)
AF:
AC:
407
AN:
14944
Ashkenazi Jewish (ASJ)
AF:
AC:
72
AN:
3424
East Asian (EAS)
AF:
AC:
0
AN:
5110
South Asian (SAS)
AF:
AC:
36
AN:
4784
European-Finnish (FIN)
AF:
AC:
464
AN:
10320
Middle Eastern (MID)
AF:
AC:
4
AN:
288
European-Non Finnish (NFE)
AF:
AC:
1467
AN:
67348
Other (OTH)
AF:
AC:
72
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
226
451
677
902
1128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.